DermaRite has significantly expanded its recent product recall due to potential bacterial contamination, now encompassing 32 different items. This widening recall impacts a range of skin substitutes and related products, raising concerns for patients and healthcare providers alike.
Initially,the recall focused on a smaller number of products,but testing revealed the presence of pseudomonas aeruginosa and Burkholderia cepacia in additional batches. These bacteria pose a serious risk, especially to individuals with compromised immune systems or open wounds.
Here’s a breakdown of what you need to know:
* The Risk: both Pseudomonas aeruginosa and Burkholderia cepacia can cause localized or systemic infections. these infections can be challenging to treat and potentially life-threatening.
* Affected Products: The expanded recall includes various sizes and lots of DermaRite’s skin substitutes, allograft products, and related wound care items. A complete list of recalled products and lot numbers is available through the FDA’s website.
* Who is Affected: This recall directly impacts hospitals,wound care facilities,and individual patients currently using these products. If you’ve recently undergone a procedure utilizing a DermaRite product, it’s crucial to contact your healthcare provider.
* What to Do: Promptly discontinue use of any recalled DermaRite product. Then, contact your doctor or the facility that provided the product for guidance.
I’ve found that proactive communication with your healthcare team is the most vital step in these situations. They can assess your individual risk and recommend appropriate monitoring or treatment if necessary.
The FDA initiated the recall after receiving adverse event reports. These reports detailed infections potentially linked to the contaminated products. Later, the company conducted internal testing, confirming the presence of the bacteria.
Here’s what healthcare professionals should do:
- Review Inventory: Immediately check your facility’s inventory for any of the recalled products.
- Quarantine Affected Lots: Isolate and quarantine any identified recalled lots to prevent further use.
- Report Adverse Events: Continue to report any suspected adverse events related to these products to the FDA’s MedWatch program.
- Patient Monitoring: Closely monitor patients who have received these products for signs of infection, such as redness, swelling, pain, fever, or pus.
furthermore, it’s important to understand that bacterial contamination in these types of products can occur during manufacturing or packaging. DermaRite is cooperating with the FDA to investigate the root cause of the contamination and implement corrective actions.
Here’s what works best when dealing with recalls like this: stay informed, be vigilant, and prioritize your health and safety. You can find the most up-to-date data on the FDA’s website and through official announcements from DermaRite.
Related reading